Contact
13 Chemin de Montifault
18800 BAUGY
France
Business Developement Manager
About us
With over 50 years of experience, ERBC Group is a leading preclinical CRO dedicated to bridging the gap between research and clinical success. We provide innovative in vitro and in vivo translational models and services that better predict the efficacy and safety of new compounds.
Our comprehensive portfolio of experimental capabilities, preclinical models, and expert consultancy empowers biopharmaceutical, chemical, agro-chemical and cosmetics industry professionals to de-risk innovation and accelerate R&D productivity.
Operating from state-of-the-art facilities in France and Italy, our highly qualified teams deliver a customer-centric approach, prioritizing the refinement of study design and execution. At ERBC, we are committed to advancing alternatives to animal testing, ensuring ethical and cutting-edge solutions for our clients.
Business offer
Efficacy and regulatory toxicology studies for drugs, chemicals, agro-chemicals, cosmetics, etc.
Laboratory Sciences: bioanalysis, clinical pathology, anaytical methods, pathology, histology technics
Central lab (clinical samples)
Toxicology studies (GLP)
Reproductive toxicology
Biomarkers
Safety pharmacology studies
New Alternative Methods: Genetic toxicoloy, in vitro toxicology
PDX models
NHP: breeding and quarantine
Activities
- Service
- Cardiology
- Genetic Diseases
- Oncology
- Nervous Central System
- Hematology
- Infectiology
- Immunology
- Ophthalmology
- Inflammation
- Target selection & validation
- Assay development in in-vitro & in-vivo models
- Immunotherapy lead generation
- Pharmacology & Biological activity
- Therapeutic efficacy
- Safety
- Immunogenicity
- Hypersensitivity & allergies
- Immunotoxicology
- Specificity
- Immunotherapy lead optimization
- Proof of concept
- Pharmacology potency
- Exploratory toxicology
- in-vitro & ex-vivo models
- in-vivo models
- Preclinical biomarkers
- Mechanism/Function
- Mechanism of action
- Safety
- PK/PD features
- Exploratory toxicology
- Research exploratory Companion biomarkers
- Animal biomarkers
- Predictive biomarkers
- Treatment efficacy
- Population stratification
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Biomarker Identification
- Research exploratory Companion biomarkers
- Bioinformatics prediction & analysis
- Ex Vivo & In Vivo Strategy
- Ex Vivo & In Vivo Strategy
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Non-clinical safety and toxicology studies
- Regulatory safety
- Regulatory safety tests
- Non-clinical safety and toxicology studies
